Rucha Patil: Advancing Haemostasis Through Science, Collaboration and Innovation at NHU 2026
Rucha Patil, Scientist at Department of Haemostasis and Thrombosis, ICMR- National Institute of Immunohaematology, shared a post on LinkedIn:
“NHU 2026 | Advancing Haemostasis Through Science, Collaboration and Innovation
The 15th National Haemostasis Update (NHU) 2026, held on 1–2 August 2026 in Bengaluru, Organised by the Indian Association for Haemophilia and Allied Disorders (IAHAD) brought together clinicians, nurses, physiotherapists, researchers, and allied healthcare professionals from across India with a shared vision of advancing care for people with haemophilia and other bleeding disorders.
The conference concluded on an exceptionally proud note, with three outstanding laboratory research studies from our team being awarded the Best Poster Awards:
- A Novel Emicizumab-Compatible Lateral Flow Immunoassay for Rapid Detection of Factor VIII Inhibitors
(Rucha Patil, Sharda Shanbhag, Sweta Kaskar, Moni Singh) - Immunogenetic Basis of Factor VIII Inhibitor Development in Severe Haemophilia A Patients: Integrated Analysis of Immune Cell Profiling, Cytokine Signatures, Immune Gene Polymorphisms & Whole Exome Sequencing (sharda shanbhag, Karishma Vyas, Bipin Kulkarni, Rucha Patil)
- Prenatal Insight into a Rare Dual-Lineage Compound Heterozygous Female Foetus Affected by Haemophilia A(Karishma Vyas, Nikesh Kawankar, Babita Phartyal, Rucha Patil, Bipin Kulkarni, Sharda Shanbhag)
Adding another moment of pride, the Best Oral Presentation Award was for:
Real-World Clinical Experience with Very Low-Dose Emicizumab Prophylaxis in Hemophilia A: ‘A Single-Centre Study from a Tertiary Care Institute’ a KEM-ICMR study (Kalpita Pai, Rucha Patil, Kirti Patil, Jai Juverkar, Sayali Rasal)
These recognitions reflect the dedication, teamwork, and commitment of our group towards advancing innovative diagnostics, precision medicine, and improved therapeutic strategies in haemophilia care.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation